ACORN CAPITAL ADVISORS, LLC 13F Holdings

CIK 0002054410 · NEW YORK, NY

As of Sep 30, 2025, ACORN CAPITAL ADVISORS, LLC reported 20 positions worth 97.0M in its SEC Form 13F filing.

Top 20 holdings

SecurityTickerSectorSharesValue% of portfolio
CG ONCOLOGY INCCGONHealthcare1,131,501$45.6M23.14%
UROGEN PHARMA LTDURGNHealthcare1,259,749$25.1M12.76%
PUMA BIOTECHNOLOGY INCPBYIHealthcare4,131,299$21.9M11.14%
TREVI THERAPEUTICS INCTRVIHealthcare2,144,844 9.6M9.96%
TERNS PHARMACEUTICALS INCTERNHealthcare1,971,264 4.8M7.52%
CANDEL THERAPEUTICS INCCADLHealthcare2,580,517 3.2M6.68%
BICARA THERAPEUTICS INCBCAXHealthcare643,382 0.2M5.16%
ONKURE THERAPEUTICS INCOKURHealthcare2,839,674$7.8M3.96%
PROTARA THERAPEUTICS INCTARAHealthcare1,752,115$7.6M3.87%
VERASTEM INCVSTMHealthcare779,498$6.9M3.49%
CYBIN INCCYBNHealthcare734,394$4.3M2.19%
CARDIFF ONCOLOGY INCCRDFHealthcare1,962,084$4.0M2.05%
AURA BIOSCIENCES INCAURAHealthcare595,744$3.7M1.87%
BIOATLA INCBCABHealthcare4,835,111$3.3M1.69%
JASPER THERAPEUTICS INCJSPRHealthcare1,382,640$3.3M1.67%
WHITEHAWK THERAPEUTICS INCWHWKHealthcare1,139,363$2.2M1.10%
Q32 BIO INCQTTBHealthcare803,425 .6M0.81%
X4 PHARMACEUTICALS INCXFORHealthcare273,349$934.9K0.47%
ACRIVON THERAPEUTICS INCACRVHealthcare405,237$733.5K0.37%
VYNE THERAPEUTICS INCVYNEHealthcare586,572 99.4K0.10%